Islets of Hope

Volume 1, Issue 10:  October 2005

islets of hope home buttondiabetes law buttonchildren with diabetes, right to educationaffiliate products and servicesdiabetes news buttonclincal trials, research, studies buttonamazon diabetes books and magazines

Last Updated:  Monday, October 17, 2005            

Headline News
Drug Recalls & Developments
Stem Cell Research
  Diabetes Technology  *  Diabetes Legislation  *  Diabetes Events
        Islet Cell Transplanation  *  
General Diabetes Studies

diabetes headlines news archives button

Islets of News Editorial Feature

Is There Cause for Concern in the Classroom?

The American Federation of Teachers (AFT) has taken steps to prohibit anyone but a registered nurse from providing in-school diabetes care for your child.  Competent  non-medical personnel already trained to care for our children would be prohibited from doing so in the future if the AFT objectives are met.  

Read the Article: The Three Rís:  Ridiculous, Restrictive Resolutions:  Proposed Changes in Your Childís Education Plan That Do Not Make The Grade



Important Medical Disclaimer
Material on this site is intended for informational purposes only and should not be used for self- diagnosis or self-treatment. The IOH strongly recommends you seek the advice of a competent medical professional for diagnosis and treatment options, or before making any changes to your diabetes care plan

 Product Watch

Animas offers free iPod nano to purchases of Animas pumps (10/2005) ...  Find out more


 Diabetes Drugs Approved in 2005

Increlex (mecasermin), a drug from Tercicia was approved fby the FDA in August 2005 for the treatment of growth failure in pediatric patients.  Increlex contains recombinant-DNA- engineered human insulin-like growth factor-1 (rhIGF-1).  It is designed to replace natural IGF-1 in pediatric patients who are deficient, promoting normal stature growth.

ActoPlus Met - Takeda Pharmaceutical Co. has obtained U.S. Food and Drug Administration approval for a new combination of insulin sensitizing drugs, Actoplus Met is a combination of Actos and Metformin.  Associated Press, August 30, 2005.

Byettaa (exenatide) - Derived from a compound found in the saliva of the Gila monster, a large lizard native to the southwestern US, mimics the function of GLP-1, the drug helps more strongly activate this pathway to improve glycemic control and is indicated for type 2 treatment.

Symlin (pramlintide)  - A synthetic form of the hormone amylin normally produced by the beta cells along with insulin.  Amylin, insulin, and a third hormone called glucagon all work together to maintain normal glucose levels.  Studies show a modest improvement in A1C levels for individuals adding pramlintide to their diabetes care routine.


Trouble with Novolog? Is your pharmacist mixing up Mix 70/30 and Rapid?

On 08/26/05, Novo Nordisk Incorporated and the US Food and Drug Administration notified pharmacists of an initiative implemented to help prevent dispensing errors with Novolog Rapid and Novolog Mix 70/30 insulins ...

DANA Diabecare Warned by FDA: Failure to Report Insulin Pump Problems

DANA Diabecare was warned by FDA in July 2005 that " its procedures for reporting adverse events associated with the DANA Diabecare II pump were inadequate"   when pump users reported serious injury as a result of device problems and the information was not properly reported by DANA Diabecare.

Clinical Trial Update
Clinical Trials Resource List

Arkansas - University of Arkansas for Medical Sciences Study seeks participation for newly diagnosed type 1 patients (within the past 6 weeks) ages 12-35 years.  Some compensation. 

Buyer Beware

Counterfeit Lipitor recall 07/29/05 ...

Halloween Candy Scare?

If you are worried about Halloween candy ruining your child's next A1c you can still let your child have the fun of Trick-or- Treating without the high-sugar worries.  Keep all the candy that can be used for fast sugars and a couple of others for occasional "treats." Then offer to exchange the remaining candy for a toy, special time with a parent, or even cash!

Have a safe and happy Halloween!


Inhaled Insulin May Only Be A Breath Away From FDA Approval

FDA Panel Urges Approval of Inhaled Insulin:  Exubera Offers People With Diabetes an Alternative to Insulin Injections.  Sept. 8, 2005 (Washington) -- A government advisory panel has backed approval of the first insulin inhaler. The device offers people with diabetes an alternative to insulin injections for controlling their blood sugar.  Todd Zwilich, Wed Md News, September 8, 2005.

Flu Season Brings New Cautions for Anti-Nausea Drug in Pediatric Use

Phenergan can cause death in children under age 2.

JDRF Annual Walk For a Cure Highlights From Ontario, CA (09/10/05)

The Juvenile Diabetes Research Foundation (JDRF) teamed up with the Red Cross for a fabulous fundraising walk.  Both the diabetes community and Gulf Coast area victims of hurricane Katrina benefited from this fabulous program.  JDRF volunteers organize annual walks all over the country each year raising millions of dollars to help further the cause of those with diabetes. The Ontario, CA walk alone raised more than $240,000.00!

See highlights from a fun-filled day with meaning -- the JDRF Annual Walk for A Cure event that was hosted in Ontario, CA.  IOH founder Lahle and her children attended raising more than $1,000.00 for the JDRF.


Contact Us  |  About IOH  |  Our Mission  |  Elizabeth's Story  |  About the Founder  |  Join IOH  |  How To Help  |  Advertise with Us  | |  Site Index  |


                                      insulin pumps for underinsured mellitus patients

Page Updated 12/09/2005